Patents Assigned to DXTERITY DIAGNOSTICS
-
Patent number: 10829803Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more oligonucleotide probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligated oligonucleotide product. In accordance with the invention, the presence of the target(s) of interest can be determined by measuring the presence or amount of ligated oligonucleotide product.Type: GrantFiled: May 10, 2007Date of Patent: November 10, 2020Assignee: DXTERITY DIAGNOSTICS INCORPORATEDInventor: Robert Terbrueggen
-
Patent number: 10463347Abstract: The present invention generally relates to devices and methods for collecting and stabilizing biological samples, and more particularly, for collecting and stabilizing blood or other bodily fluids from a user's fingertip, earlobe, heel or other locations. The present invention also relates to sample collection devices that simplify the process for mixing the biological samples with an additive or additives, provide for efficient storage and safe transport of the samples, and provide for easy access to the samples for subsequent processing.Type: GrantFiled: September 8, 2017Date of Patent: November 5, 2019Assignee: DXTERITY DIAGNOSTICS INCORPORATEDInventors: Robert Terbrueggen, Scott Gordon Beach
-
Patent number: 10066257Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.Type: GrantFiled: May 17, 2012Date of Patent: September 4, 2018Assignee: DXTERITY DIAGNOSTICS INCORPORATEDInventors: Robert Terbrueggen, Yenbou Liu, John Ray Childers, Jr., Chang Hee Kim, Majid R. Abedi
-
Patent number: 9976177Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more oligonucleotide probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligated oligonucleotide product. In one aspect, the ligation product is of variable length that correlates with a particular target. Following chemical ligation, the probes may be amplified and detected by capillary electrophoresis or microarray analysis.Type: GrantFiled: March 29, 2010Date of Patent: May 22, 2018Assignee: DXTERITY DIAGNOSTICS INCORPORATEDInventor: Robert Terbrueggen
-
Patent number: 9757095Abstract: The present invention generally relates to devices and methods for collecting and stabilizing biological samples, and more particularly, for collecting and stabilizing blood or other bodily fluids from a user's fingertip, earlobe, heel or other locations. The present invention also relates to sample collection devices that simplify the process for mixing the biological samples with an additive or additives, provide for efficient storage and safe transport of the samples, and provide for easy access to the samples for subsequent processing.Type: GrantFiled: June 10, 2015Date of Patent: September 12, 2017Assignee: DXTERITY DIAGNOSTICS INCORPORATEDInventors: Robert Terbrueggen, Scott Gordon Beach
-
Patent number: 9745616Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.Type: GrantFiled: May 17, 2012Date of Patent: August 29, 2017Assignee: DXTERITY DIAGNOSTICS INCORPORATEDInventors: Robert Terbrueggen, Yenbou Liu, John Ray Childers, Jr., Chang Hee Kim, Majid R. Abedi
-
Publication number: 20140171338Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.Type: ApplicationFiled: May 17, 2012Publication date: June 19, 2014Applicant: DXTERITY DIAGNOSTICS INCORPORATEDInventors: Robert Terbrueggen, Yenbou Liu, John Ray Childers, Chang Hee Kim, Majid R. Abedi
-
Publication number: 20130005594Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.Type: ApplicationFiled: May 17, 2012Publication date: January 3, 2013Applicant: DxTerity Diagnostics IncorporatedInventors: Robert Terbrueggen, Yenbou Liu, John Ray Childers, JR., Chang Hee Kim, Majid R. Abedi
-
Publication number: 20110306512Abstract: A method is provided in various embodiments for determining a profile data set for a subject with osteoarthritis or conditions related to osteoarthritis based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least one constituent from Tables 1-2, 4-6, and 8. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.Type: ApplicationFiled: June 25, 2009Publication date: December 15, 2011Applicant: DxTerity DiagnosticsInventors: Danute M. Bankaitis-Davis, Lisa Siconolfi, Kathleen Storm, Karl Wassmann
-
Publication number: 20080124810Abstract: The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more oligonucleotide probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligated oligonucleotide product. In accordance with the invention, the presence of the target(s) of interest can be determined by measuring the presence or amount of ligated oligonucleotide product.Type: ApplicationFiled: May 10, 2007Publication date: May 29, 2008Applicant: DXTERITY DIAGNOSTICSInventor: Robert Terbrueggen